For patients at JosephCareRX, a good candidate for GLP-1 weight loss medications is typically an adult with a body mass index (BMI) of 30 or higher
This supports prioritizing GLP-1RA over insulin in patients requiring intensive glycemic control, potentially offering additional hepatoprotective benefits (Yang et al., 2024)
Access issues have major consequences
Lets talk about whats possible for your health
Unfortunately, private coverage remains equally problematicfew insurance companies provide coverage for second-generation medications like GLP-1 receptor agonists, often requiring diabetes as a prerequisite for prescription coverage
He L, Wang J, Ping F, Yang N, Huang J, Li Y, et al